As the U.S. healthcare system continues to make the shift from volume to value, stakeholders are taking on new approaches to adapt and thrive in this changing environment. Quality measurement is playing a more prominent role to ensure effective and efficient care for patients.
Join Avalere and Eisai as they explore the latest trends in cancer care. Kristi Mitchell, Senior Vice President of Avalere’s Evidence Translation and Implementation team, will lead the discussion. She’ll be joined by Dr. Bradford Hirsch of Medical oncologist at Texas Oncology, Senior Medical Director at Flatiron Health and Co-Founder & Board of Directors, SignalPath Research, Dr. Michael Kolodziej of Aetna and Kristin McNiff of Dana-Farber Cancer Institute and Shelley Fuld Nasso of the National Coalition of Cancer Survivorship.
Kristi Mitchell and panelists will discuss:
- Quality measurement gaps and opportunities
- New approaches to enhancing patient engagement
The role of data in improving outcomes